Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM

被引:35
作者
Hubinger, A
Knode, O
Susanto, F
Reinauer, H
Gries, FA
机构
[1] Diabetes Research Institute, Düsseldorf
[2] Diabetes Research Institute, Heinrich-Heine-University, D-40225 Düsseldorf
关键词
carnitine-acyltransferase; Etomoxir; insulin resistance; Cori-cycle;
D O I
10.1055/s-2007-979072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the influence of Etomoxir on fat and carbohydrate oxidation, and the influence of these changes on insulin sensitivity in type 2 diabetic patients, Etomoxir is an oxirane carboxylic acid derivative that specifically inactivates carnitine-acyltransferase I (CAT I, EC: 2.3.1.21), the key enzyme for the transport of long-chain acyl-CoA compounds into the mitochondria. Thus, oxidation of fatty acids should be reduced by this drug and glucose utilisation be increased according to the Randle mechanism, in order to test this hypothesis, we measured oxidative and non-oxidative glucose utilisation using the euglycaemic hyperinsulinaemic clamp technique, the isotope dilution mass spectrometry (IDMS) method with stable isotopes (6,6-D-2-glucose) and indirect calorimetry. The clamps lasted 5 hours, indirect calorimetry was performed during the last hour and calculations of glucose disposal were based on steady state conditions during the last 30 minuter. Twelve type 2 diabetic patients were treated with 100 mg etomoxir/per day for 3 days in this placebo-controlled, randomized, double-blind study, Treatment resulted in a significant increase in carbohydrate oxidation (from 72 to 113 g/24 h, p = 0.039), decrease in fat oxidation (from 139 to 114 g/24 h, p = 0.037), and decrease of the glucose appearance rate (RA) in the basal state (from 1.85 to 1.70 mg/kg min., p = 0.014). During the euglycaemic clamp neither RA (3.30 and 3.20 mg/kg min., p = 0.471) nor the glucose infusion rate (4.28 and 4.53 mg/kg min., p = 0.125) showed significant changes, In addition, no significant changes in glucose and fat oxidation were detected during the hyperinsulinaemic clamp, Under basal conditions non-oxidative glucose utilisation was decreased by etomoxir (1.26 and 0.80 mg/kg x min), Thus, we could demonstrate a decrease in fat and increase in glucose oxidation by etomoxir, but non-oxidative glucose utilisation was decreased, No significant changes could be demonstrated under clamp conditions.
引用
收藏
页码:436 / 439
页数:4
相关论文
共 22 条
[1]   EFFECT OF FATTY-ACID OXIDATION-INHIBITION ON GLUCOSE-METABOLISM IN DIABETIC RATS [J].
COLLIER, GR ;
TRAIANEDES, K ;
MACAULAY, SL ;
ODEA, K .
HORMONE AND METABOLIC RESEARCH, 1993, 25 (01) :9-12
[2]   CHARACTERIZATION OF CELLULAR DEFECTS OF INSULIN ACTION IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
DELPRATO, S ;
BONADONNA, RC ;
BONORA, E ;
GULLI, G ;
SOLINI, A ;
SHANK, M ;
DEFRONZO, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02) :484-494
[3]   NONESTERIFIED FATTY-ACIDS REGULATE LIPID AND GLUCOSE-OXIDATION AND GLYCOGEN-SYNTHESIS IN HEALTHY MAN [J].
EBELING, P ;
KOIVISTO, VA .
DIABETOLOGIA, 1994, 37 (02) :202-209
[4]   ROLE OF LIPID OXIDATION IN PATHOGENESIS OF INSULIN RESISTANCE OF OBESITY AND TYPE-II DIABETES [J].
FELBER, JP ;
FERRANNINI, E ;
GOLAY, A ;
MEYER, HU ;
THEIBAUD, D ;
CURCHOD, B ;
MAEDER, E ;
JEQUIER, E ;
DEFRONZO, RA .
DIABETES, 1987, 36 (11) :1341-1350
[5]   THE THEORETICAL BASES OF INDIRECT CALORIMETRY - A REVIEW [J].
FERRANNINI, E .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (03) :287-301
[6]   RATIONALE AND APPLICATION OF FATTY-ACID OXIDATION INHIBITORS IN TREATMENT OF DIABETES-MELLITUS [J].
FOLEY, JE .
DIABETES CARE, 1992, 15 (06) :773-784
[7]   AMBIENT PLASMA-FREE FATTY-ACID CONCENTRATIONS IN NONINSULIN-DEPENDENT DIABETES-MELLITUS - EVIDENCE FOR INSULIN RESISTANCE [J].
FRAZE, E ;
DONNER, CC ;
SWISLOCKI, ALM ;
CHIOU, YAM ;
CHEN, YDI ;
REAVEN, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (05) :807-811
[8]   RELATIONSHIPS BETWEEN PLASMA-FREE FATTY-ACID CONCENTRATION, ENDOGENOUS GLUCOSE-PRODUCTION, AND FASTING HYPERGLYCEMIA IN NORMAL AND NON-INSULIN-DEPENDENT DIABETIC INDIVIDUALS [J].
GOLAY, A ;
SWISLOCKI, ALM ;
CHEN, YDI ;
REAVEN, GM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (07) :692-696
[9]   THE ROLE OF FREE FATTY-ACID METABOLISM IN THE PATHOGENESIS OF INSULIN RESISTANCE IN OBESITY AND NONINSULIN-DEPENDENT DIABETES-MELLITUS [J].
GROOP, LC ;
SALORANTA, C ;
SHANK, M ;
BONADONNA, RC ;
FERRANNINI, E ;
DEFRONZO, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (01) :96-107
[10]   THE EFFECT OF ETOMOXIR ON INSULIN SENSITIVITY IN TYPE-2 DIABETIC-PATIENTS [J].
HUBINGER, A ;
WEIKERT, G ;
WOLF, HPO ;
GRIES, FA .
HORMONE AND METABOLIC RESEARCH, 1992, 24 (03) :115-118